影响药物渴望的危险和保护因素 患有物质使用障碍的患者 接受阿片类抗原剂维持治疗的阿片类抗原剂维持治疗
Gholamreza Kheirabadi1, Masoud Asadi2, Mohammad Niroumand Sarvandani3,4
1Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Substance use & misuse
|August 21, 2023
概括
与物质相关的信念显著影响了物质使用障碍 (SUD) 患者的渴望. 针对这些信念的干预措施和促进自我弹性可以帮助治疗.
科学领域:
- 精神病学和行为科学
- 成 药物 药物 药物 药物
- 临床心理学 临床心理学
背景情况:
- 药物使用障碍 (SUD) 是一个重大的公共卫生挑战.
- 渴望是SUD复发和治疗结果的关键因素.
- 了解渴望的风险和保护因素对于有效的干预至关重要.
研究的目的:
- 调查影响SUD患者渴望的风险和保护因素.
- 检查自我弹性,认知情绪调节和与物质有关的信念的作用.
- 在伊朗伊斯法罕接受维持治疗 (布普诺芬,甲,片) 的患者中分析这些因素.
主要方法:
- 横截面路径分析模型涉及482名接受维持治疗的SUD患者.
- 数据采集使用验证的问卷:阿片类嗜好问卷 (OCQ),与物质有关的信念问卷 (SRBQ),认知情绪调节问卷 (CERQ),患者健康问卷,家庭弹性评估量表 (FRAS) 和自我弹性量表 (SRS).
- 用于数据分析的路径分析和部分最小平方 (PLS) 软件.
主要成果:
- 自我性 (β=-0.147,p=0.009) 和不妥协的策略 (β=0.249,p=0.0001) 显著影响了抑郁症.
- 对药物的信仰 (β=0.518,p=0.0001) 和抑郁 (β=0.219,p=0.0001) 对渴望有显著的直接影响.
- 与物质相关的信念被确定为渴望的关键因素.
结论:
- 与物质相关的信念在SUD患者的渴望中发挥着实质性的直接和间接作用.
- 自我性和认知情绪调节策略影响抑郁症,这反过来影响渴望.
- 这些发现支持针对SUD患者开发有针对性的教育和治疗干预措施.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
512
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
512
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Analgesia and Pain Management
654
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
654
Opioid Analgesics: Synthetic and Semisynthetic Opioids
335
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
335
Substance Use Disorders Affecting Sleep
196
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
196
Opioid Receptors: Overview
1.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.0K


